Hospital Practices and Research

A Comparative Analysis of Clinical Characteristics, Laboratory Findings, and Radiological Manifestations of Hospitalized COVID-19 Patients with and without Atopy: A Single-Center Cross-Sectional Study with Matched Controls

Document Type : Original Article

Authors

Mojtaba Ahmadzadeh-Darinsoo 1
Mostafa Akbariqomi 2
Morteza Ahmadzadeh-Darinsoo 1
Ensieh Vahedi 3
Hamid Babavalian 4
Mohammad Sadegh Hashemzadeh 4
Seyyed Hossein Hasheminejad 5
Manochehr Zoheyri 6
Hamid Reza Javadi 4
Ramezan Ali Taheri 4
Mahdi Bagheri 7
Morteza Mirzaei 1

1 Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Tissue Engineering and Regenerative Medicine Research Center, Baqiyatallah University of Medical Sciences, Tehran, IranTehran, Iran

3 Chemical Injuries Research Center, Systems Biology and Poisoning Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

4 Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

5 Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

6 Behavioral Science Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

7 Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

https://doi.org/10.30491/hpr.2024.453010.1423
Abstract
Background: The coronavirus Disease 2019 (COVID-19) pandemic emerged in December 2019, resulting in a high number of deaths worldwide. There is a need to investigate how this condition affected people with different diseases, particularly atopy.
Objectives: This study aimed to compare clinical symptoms, laboratory test results, radiological manifestations, and clinical outcomes between hospitalized COVID-19 patients with and without atopy.
Methods: This single-center cross-sectional study with matched controls was conducted on 106 (out of 334) COVID-19 patients hospitalized in Baqiyatallah Hospital, Tehran, Iran, from March 24 to April 24, 2020. Among them, there were 40 and 66 cases with and without atopy, respectively. The non-atopic patients were also matched with the atopic patients in terms of age, gender, Body Mass Index (BMI), and the prevalence of comorbidities, particularly hypertension and diabetes. Patients' clinical characteristics, laboratory findings, and radiological features, recorded upon their admission, and the outcomes were then compared between both study groups.
Results: Compared with the non-atopic group, weakness, myalgia, and chills were more frequent in the patients affected with atopy (P <0.05), and neutrophil count, Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), bilateral lung involvement, bilateral pneumonia, and Ground-Glass Opacity (GGO) were among the laboratory test results and radiological manifestations that were observed significantly less in atopic patients (P <0.05). No significant difference was further detected regarding the COVID-19 outcomes in both study groups (P >0.05).
Conclusion: This study showed that atopic conditions were capable of increasing the frequency of some COVID-19 clinical symptoms and reducing the severity of COVID-19 with regard to laboratory findings and radiological features on admission. In addition, atopy was not correlated with COVID-19 outcomes in atopic patients.

Keywords

Atopy
Clinical Characteristics
COVID-19
Hospitalized Patient
  1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60. doi:23750/abm.v91i1.9397
  2. Klhůfek J. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?. Acta Clin Belg. 2022;77(1):211-8. doi:10.1080/17843286.2020.1786324
  3. Mahase E. Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports. 2021;375:n2713. doi:10.1136/bmj.n2713
  4. Rodriguez-Guerra M, Jadhav P, Vittorio TJ. Current treatment in COVID-19 disease: a rapid review. Drugs Context. 2021;10. doi:7573/dic.2020-10-3
  5. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): Weekly epidemiological update on COVID-19 - 25 May 2022. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---25-may-2022 (accessed 28 May 2022)
  6. Carr TF, Kraft M. Asthma and atopy in COVID-19: 2021 updates. J Allergy Clin Immunol. 2022;149(2): 562-4. doi:10.1016/j.jaci.2021.12.762
  7. Vaillant AAJ, Modi P, Jan A. Atopy. StatPearls [Internet]: StatPearls Publishing; 2020.
  8. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75(7):1730-41. doi:10.1111/all.14238
  9. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1):110-8. doi:10.1016/j.jaci.2020.04.006
  10. Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M. Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125(4):479-81. doi:1016/j.anai.2020.07.012
  11. Scala E, Abeni D, Tedeschi A, Manzotti G, Yang B, Borrelli P, et al. Atopic status protects from severe complications of COVID-19. Allergy. 2021;76(3):899-902. doi:10.1111/all.14551
  12. Yang JM, Koh HY, Moon SY, Yoo IK, Ha EK, You S, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790-8. doi:10.1016/j.jaci.2020.08.008
  13. Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, Visness CM, Durham SR, Larson D, Esnault S, Ober C. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1): 203-6. doi:10.1016/j.jaci.2020.04.009
  14. Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable?. Biol Sex Differ. 2020;11(1):53. doi:10.1186/s13293-020-00330-7
  15. Garg S. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-64. doi:10.15585/mmwr.mm6915e3
  16. Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020;12:57. doi:10.1186/s13098-020-00565-9
  17. Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients. Allergy. 2021;76(2):533-50. doi:10.1111/all.14496
  18. Wong CK, Wong JY, Tang EH, Au CH, Wai AK. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Rep. 2020;10(1):19765. doi:10.1038/s41598-020-74988-9
  19. Statsenko Y, Al Zahmi F, Habuza T, Almansoori TM, Smetanina D, Simiyu GL, et al. Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings. Front Cell Infect Microbiol. 2022; 11:777070. doi:10.3389/fcimb.2021.777070
  20. Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154-64. doi:3947/ic.2020.52.2.154
  21. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. lancet. 2020;395(10239):1763-70. doi:10.10 16/S0140-6736(20)31189-2
  22. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102. doi:10.1056/NEJMoa2007621
  23. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-9. doi:10.1016/j.jiph. 2020.07.014
  24. Yang J, Zheng YA, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. doi:10.1016/j.ijid.2020.03.017
  25. Nouri-Vaskeh M, Khalili N, Sharifi A, Behnam P, Soroureddin Z, Ade EA, et al. Clinical characteristics of fatal cases of COVID-19 in Tabriz, Iran: an analysis of 111 patients. Front Emerg Med. 2021;5(1):e12. doi:10.22114/ajem.v0i0.499
  26. Ahmadzadeh-Darinsoo M, Akbariqomi M, Ahmadzadeh-Darinsoo M, Ranjbar R, Arabfard M, Razei A, et al. Clinical Features of COVID-19 Hospitalized Patients with and without Chronic Kidney Disease: A Single-Center, Cross-Sectional Study. Electron J Gen Med. 2022;19(2):em345. doi:10.29333/ejgm/11544
  27. Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Invest. 2020;80(6):441-7. doi:10.1080/00365513.2020.1768587
  28. Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21:74. doi:10.1186/s12931-020-01338-8
  29. Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz R, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med. 2020;9(6): 1753. doi:10.3390/jcm9061753
  30. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. lancet. 2020;395 (10223):507-13. doi:10.1016/S0140-6736(20)30211-7
  31. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet. 2020;395 (10223):497-506. doi:10.1016/S0140-6736(20)30183-5
  32. Akbariqomi M, Hosseini MS, Rashidiani J, Sedighian H, Biganeh H, Heidari R, et al. Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran. Diabetes Res Clin Pract. 2020;169:108467. doi:10.10 16/j.diabres.2020.108467
  33. Sarmin M, Mahfuz M, Shahrin L, Shaly NJ, Shaima SN, Shikha SS, et al. Comparative clinical characteristics, laboratory findings, and outcomes of hypoxemic and non-hypoxemic patients treated at a Makeshift COVID-19 unit in Bangladesh: a retrospective chart analysis. J Clin Med. 2022;11(11): 2968. doi:10.3390/jcm11112968
  34. Timberlake DT, Narayanan D, Ogbogu PU, Raveendran R, Porter K, Scherzer R, et al. Severity of COVID-19 in hospitalized patients with and without atopic disease. World Allergy Organ J. 2021;14(2): 100508. doi:10.1016/j.waojou.2021.100508
  35. Guvey A. How does allergic rhinitis impact the severity of COVID-19?: a case–control study. Eur Arch Otorhinolaryngol. 2021;278(11):4367-71. doi:10.1007/s00405-021-06836-z
Hospital Practices and Research
Volume 9, Issue 1 - Serial Number 33
Winter 2024
Pages 389-395

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us